Myelodysplastic Syndromes (MDS): Progress, Possibility, and What’s Next

You cannot have progress without research.

In our latest episode, Dr. Jay Yang of the Karmanos Cancer Institute in Detroit, MI, breaks down the essentials of MDS care, from risk-based treatment plans to managing fatigue and exploring promising new therapies. Tune in to find out why the future of MDS treatment is brighter than ever.

CLICK HERE to participate in our episode survey.

Mentioned on this episode: 

• Myelodysplastic syndromes (MDS)
• MDS patient videos
• Acute myeloid leukemia (AML)
• Allogeneic stem cell transplant
• Graft-vs-host disease
• Clinical Trial Support Center

Additional Blood Cancer United Support Resources: 

• Information Specialists 
• Free Nutrition Consultations
• Free telephone/web patient programs 
• SHARE web series
• Online videos
• Free booklets 
• Young Adult Resources
• Young Adult Online Chat
• Support groups 
• Patient Community
• Caregiver support
• Caregiver Workbook
• Medical Debt Case Management Program
• Financial support
• Survivorship Workbook
• Advocacy and Public Policy
• Mental Health Resources

Episode supported by Bristol Myers Squibb and Taiho Oncology, Inc.

The post Myelodysplastic Syndromes (MDS): Progress, Possibility, and What’s Next first appeared on The Bloodline with Blood Cancer United Podcast.